Abiomed, Inc. Starts Its Fiscal Year on a High Note
Abiomed (NASDAQ: ABMD), a medical-device company focused on minimally invasive heart pumps, reported its fiscal first-quarter earnings on Thursday, July 27. The company's results proved yet again that healthcare providers from around the world are warming up to the idea of using the company's Impella family of heart pumps during surgery.
Let's dissect the company's fiscal first-quarter results to learn more about how it performed during the period.
Image source: Getty Images.
Source: Fool.com